TABLE 4.
cASTs with FDA clearance for current CLSI breakpointsa
| Organism group | Antimicrobial agent | BD phoenix | Beckman coulter MicroScan | bioMérieux Vitek 2 | Thermo Fisher Sensititre |
|---|---|---|---|---|---|
| Enterobacteriaceae | Cefepime | Y | N | Y | Y |
| Cefotaxime | N | Y | Y | Y | |
| Ceftriaxone | Y | Y | Y | Y | |
| Ceftazidime | N | N | N | N | |
| Ertapenem | Y | Y | Y | Y | |
| Imipenem | Y | Y | Y | Y | |
| Meropenem | Y | N | N | Y | |
| Enterobacteriaceae (Salmonella) | Ciprofloxacin | S. typhi | S. typhi; S. enteritidis | ||
| Pseudomonas aeruginosa | Imipenem | Y | Y | Y | Y |
| Meropenem | Y | Y | N | Y | |
| Piperacillin-tazobactam | Y | N | N | Y | |
| Acinetobacter spp. | Imipenem | Y | Y | Y | Y |
Includes agents for which FDA and CLSI MIC breakpoints are the same. Y, yes breakpoints current with CLSI/FDA breakpoints; N, no breakpoints, not current with CLSI/FDA breakpoints. Contact manufacturer for updated information on those breakpoints listed as not yet current here.